Plunkett Research Online: Nile Therapeutics Inc

NILE THERAPEUTICS INC (NLTX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Nile Therapeutics, Inc. is a development stage biopharmaceutical company, engaged in commercially developing products for the treatment of cardiovascular diseases. It currently has two drug candidates in development: Cenderitide and CU-NP, its main product candidate, is a chimeric natriuretic peptid.....


NILE THERAPEUTICS INC

Ticker: NLTX
Exchange: PINX
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 650 458-2670
Fax: 415 875-7075
Address: 4 West 4th Avenue
San Mateo, CA 94402 United States

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Nile Therapeutics, Inc. is a development stage biopharmaceutical company, engaged in commercially developing products for the treatment of cardiovascular diseases. It currently has two drug candidates in development: Cenderitide and CU-NP, its main product candidate, is a chimeric natriuretic peptid.....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture